Antidepressants are prescribed to be irritable when it is suspected that chemical imbalance is the cause of unnecessary emotional disorders. Many of the drugs approved by the US Food and Drug Administration for the treatment of depression also have a positive impact on anxiety levels. Irritableness is often seen as a secondary symptom of a disorder manifested by an anxiety spectrum. For this reason, certain antidepressants are often at the forefront of many psychiatric practices.
Paroxetine
Paroxetine is a chemical that is almost exclusively used in the brain for serotonin and is the only approved drug in the US market for the treatment of anxiety. The medicine for the disease received. This is a rea son, and if you seek help for an anxiety disorder, it is often used as the first line of defense. A study published in the October 2001 issue of the Journal of Psychopharmacology deals with the specific role of serotonin in social domination and association behavior, both of which can lead to significant irritability in social contexts. The study concluded that patients treated with paroxetine for 4 to 6 weeks experienced significant symptom relief; they showed less hostility and more socialization. Another study in the 2007 Cochrane Systematic Review Database focused on generalized anxiety disorder, a factor that made it the focus of this debate, as it was diagnosed multiple times in irritability and irritability. . Study c improves the efficacy of selective serotonin reuptake inhibitors such as paroxetine and placebo pills. Paroxetine and an unrelated antidepressant, imipramine, performed very well. The main complaint of patients taking paroxetine is sometimes long-term and uncomfortable withdrawal
Venlafaxine
Venlafaxine is a serotonin and norepinephrine reuptake inhibition Agent. Dr. Wayne C. Jones of Texas reported that it was usually the first course of his practice due to its rapid onset; in some cases, significant changes occurred only after seven days. Because of its state as a norepinephrine inhibitor, the drug sometimes causes nausea or uneasiness, while the body reaches peak plasma levels and is accustomed to changes in chemical percentage. Despite these side effects, venlafaxine is generally well tolerated and does not have many adverse drug interactions. Its efficacy was tested in a study published in the Journal of the American Medical Association in 2007. Two doctors in charge of the studyJames L. Levenson and Robert K. Schneider concluded that venlafaxine is more effective than placebo. For the treatment of generalized anxiety disorder
imipramine
imipramine belongs to an earlier class of antidepressants, tricyclic drugs. Although drugs are not usually used as a first-line defense against anxiety or depression, they are often used when other drugs are not effective. Dr. Laszlo A. Papp of Brown University explained that in the early 1960s it was the first non-addictive drug to show the efficacy of treating anxiety disorders. Its efficacy is still competitive in today's saturated antidepressant market, as previously reported, in 2007, imipramine was comparable to paroxetine.
Sertraline
Sertraline, another selective serotonin reuptake inhibitor, approved for the treatment of anxiety, with or without concurrent depression, in the third ring Drugs are less popular with prescription doctors. It is sometimes considered the "gold standard" for comparing other antidepressants. For example, the University of Michigan used sertraline as a base drug in a study conducted in 2008, while testing other possible drug candidates for depression and anxiety. For adolescents and pregnant women, sertraline is generally considered to be the safest, keeping it in the list of medications used to treat anxiety and depression.
